Identity
- Type
- company
- Country label
- USA
- HQ country
- USA
- Founding country
- USA
- Parent
- not in the notes
- Parent country
- not in the notes
- Country basis
- the research notes
Where this comes from
Convention D1: a dual label, HQ first, when the HQ, founding or parent country differ.
Models by Class
Models
ModelClassOpennessParametersReleased
Virchow2vision1 Aug 2024
Prismmultimodal LLM24 Jul 2024
Virchowvision22 Jul 2024Links
Organisation
Paigecompany, USA
Paigecompany, USAWho Runs Itnone recorded
Scores
| Benchmark | Model | Score | Who ran it | Setting |
|---|---|---|---|---|
| Pan-cancer specimen-level detection (Virchow study) | Virchow | 0.95 AUROC | vendor-reported | As reported in the Virchow paper |
Where this comes from
Every recorded score of this organisation's models, with who ran it. Scores from different settings are not directly comparable.
Sources
- A foundation model for clinical-grade computational pathology and rare cancers detection - Nature Medicine nature.com https://www.nature.com/articles/s41591-024-03141-0
To cite this page: Project AURION, AI Use-Cases Research & Innovation, "Paige", https://aurion.semai.id/organisations/paige/, records of October 2026.